Scientists are continuing to explore the role of furin proteases in the development of drugs to address COVID infections. This is a topic Dr. Fitzgerald has written on previously, including a peer-reviewed publication discussing dietary, lifestyle, and natural options to consider for lowering furin levels.
My research and analysis on the important connections between furin and SARS CoV-2 has been accepted as a preprint article on SSRN. Thank you, David Riley, for making that happen! Abstract: Furin is a protease that is ubiquitous in the mammalian metabolism. One of the innovations that make SARS-CoV-2 more infectious than its ancestor viruses…
More validation is emerging for the furin protease (“furin”) hypothesis I posited in this blog: The Furin Protease Connection: From SARS CoV-2 and Anthrax, to Diabetes and Hypertension and that is now available as a pre-print publication here. Considering furin protease inhibitors Scientists are validating furin inhibition as a possible pathway to addressing COVID. And in this Medical News Today…
Earlier this year, Coutard et al proposed that the SARS-CoV-2 spike glycoprotein (S) contains a furin cleavage complex (FCC) which was likely playing a role in the pathogenicity of this particular virus. Fast forward a few weeks, and some further connections can be made with relevance for how we might interpret risk and choose interventions…
